Application
IPO8 Antibody (N-term) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the IPO8 antibody detected the IPO8 protein (arrow).
Application
IPO8 Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human cervix carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the IPO8 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.
Application
IPO8 Antibody (N-term) flow cytometric analysis of Hela cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.